Halozyme Therapeutics shares owned by Cresset Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cresset Asset Management
from 13F filings
Historical chart of Cresset Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Cresset Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 226k | 73.34 |
| 2025-06-30 | $15M | 292k | 52.02 |
| 2025-03-31 | $20M | 306k | 63.81 |
| 2024-12-31 | $16M | 333k | 47.81 |
| 2024-09-30 | $19M | 334k | 57.24 |
| 2024-06-30 | $15M | 290k | 52.36 |
| 2024-03-31 | $11M | 281k | 40.68 |
| 2023-12-31 | $7.7M | 208k | 36.96 |
| 2023-09-30 | $6.9M | 180k | 38.20 |
| 2023-06-30 | $3.8M | 106k | 36.07 |